New York Attorney Full General Files Trial Over Namenda
The New York State’s attorney full general filed an antitrust trial on Mon seeking to halt Actavis from forcing patients alongside Alzheimer’s illness to switch to a novel version of the Alzheimer's medication Namenda.
By Bob DeMarco
Let me commencement yesteryear stating that several weeks agone it became apparent that at that spot was a national shortage of Namenda XR. In short, the drug was non available for purchase inwards many locations.
I called the ii largest pharmacies inwards the Delray Beach, FL area, in addition to neither could fill upward a prescription for Namenda XR. This of class left meg of patients living alongside Alzheimer's unable to accept a drug they were already consuming.
At the time, I called Actavis for to a greater extent than than iii hours to larn a contention in addition to clarification for our readers hither on the ARR in addition to on Facebook. I talked to seven people in addition to was assured I would larn a telephone telephone back. They never returned our call.
The is the largest weblog of its type on the Internet. We get got ever received slap-up cooperation in addition to data from pharmaceutical companies in addition to this included Forest Laboratories which was acquired yesteryear Actavis.
Actavis is trying to forcefulness user of Namenda onto the newer version of the drug (XE) spell at the same fourth dimension discontinuing the sale of the existing v in addition to 10 mg versions of Namenda.
Imagine what would give off if every fourth dimension a jail cellular telephone phone companionship issued a novel telephone that they turned off all the existing version in addition to forced you lot to purchase the novel phone. This is basically what Actavis is trying to practice you.
You should know that the electrical flow formula of Namenda volition larn generic inwards July, 2015. I would aspect the drug to drop in cost yesteryear thirty per centum immediately, in addition to and thus yesteryear to a greater extent than than xc per centum yesteryear July, 2016.
I am a fan of Namenda, and I believe the drug helped my mother.
In the non thus distant futurity all persons suffering from Alzheimer's volition hold upward able to obtain combination therapy (the generic version of Aricept in addition to Namenda) for less than $20 a month. To compare, at that spot was a fourth dimension spell I was caring for Dotty when the combined drugs cost to a greater extent than than $630 for a ane calendar month supply.
Subscribe to the Alzheimer's Reading - This is a Free Service - Join Now
The Current Situation
The New York State’s attorney full general filed an antitrust trial on Mon seeking to halt a pharmaceutical companionship from forcing patients alongside Alzheimer’s illness to switch to a novel version of a widely used drug (New York Times).
The adapt accuses Actavis of forcing patients to switch to a once-daily formulation of the same drug, Namenda XR, thus that the companionship won't confront every bit much contest when low-cost generic versions of the master copy drug hitting the marketplace seat side yesteryear side year. The the U.S. of A. patent for the master copy drug expires side yesteryear side year, spell a dissever patent for the extended-release version isn't due to expire until 2029 (Wall Street Journal)>
In a contention New York state's attorney full general said
"A drug companionship manipulating vulnerable patients in addition to forcing physicians to alter handling plans unnecessarily, only to protect corporate profits, is unethical in addition to illegal."Read to a greater extent than from these sources.
- New York Sues to Block Early Withdrawal of Alzheimer's Drug
- Forest Laboratories' Namenda Is Focus of Lawsuit
- "Forced switch" maneuver spurs trial against drugmaker
Explore in addition to Learn
What is the Difference Between Alzheimer’s in addition to Dementia
Test Your Memory for Alzheimer's in addition to Dementia (5 Best Tests)
What is Alzheimer's Disease?
The Last 25 Articles inwards the
Need Help? Search Our Award Winning Knowledge Base for Answers to your Questions, in addition to Solutions to your Problems
Original content the
Also see.
Does the Combination of Aricept in addition to Namenda Slow the Rate of Decline inwards Alzheimer's Patients
"The results of this written report should alter the agency nosotros process patients alongside Alzheimer's disease. Cholinesterase inhibitors are approved for piece of employment inwards mild to moderate dementia, spell memantine has been approved for advanced dementia. But it looks similar at that spot is an wages inwards prescribing both drugs (Aricept in addition to Namenda) every bit initial treatment."--John Growdon, MD